LoopLab’s vision is to revolutionize the medical treatment of immunological diseases by combining our extensive expertise in immunology, molecular biology, and virology to create a groundbreaking new drug modality. With this approach, we are equipping disease-relevant cells to become powerful drug nanofactories capable of targeting multiple disease hallmarks simultaneously. This innovative therapeutic strategy has the potential to create a new era of advanced and comprehensive treatments.
| Website | https://www.looplabbio.com |
| Employees | 18 (16 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Immunology Research, Drug Development, Immunotherapy, Drug Discovery, Molecular Biology, Virology Research, Pharmaceutical Research, Biotechnology, Therapeutic Development, Biomedical Research, Innovative Therapies, Biological Research, Disease Treatment, Medical Research, Preclinical Research, Clinical Trials, Life Sciences, Scientific Research |
| Competitors | Syngenta, U.S. Department of Energy (DOE), Novozymes, Amyris, LanzaTech, Geno, Zymergen, Inc., Solazyme , Inc., Ecovative, Green Biologics Ltd. +32 more (view full list) |
Looking for a particular Loop Lab Bio employee's phone or email?
Jochen Stritzker is the CEO and CSO of Loop Lab Bio.
16 people are employed at Loop Lab Bio.